Clinical Oncology SC015: Advancing Technologies In Radiation Oncology Flashcards

1
Q

Principles of RT

A

Ionising radiation (電離輻射):
1. β rays
2. γ rays
3. High energy X rays (Photons (光子))
4. Charged particles (帶電粒子) (e.g. C-11, Protons)

Tumour control is NOT achieved by direct cell kill but by producing **secondary electrons (carry high energy)
—> **
double-strand DNA breaks in nuclei
—> irreversible + permanent + fatal damage to tumour cell
—> cell death

Radiation falls off following **inverse-square law but **never drops to zero (theoretically go indefinitely, only drop to background level)
- Unit: ***Gray (Gy)

Most important background radiation:
- From universe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Goals of RT

A

Duplicating chromosomes (S phase in cell cycle) are more vulnerable to radiation
- unwinding —> double strands become single strand —> weak covalent bond —> more susceptible to radiation effect

RT:
1. Preferentially destroys tumour cells (actively proliferating esp. fasting growing tumour cells) but normal tissue cells also suffer (though to lesser extent)
—> Eradicate tumour cells while minimising damage to surrounding normal tissues

Other fast growing cells:
- Hair follicles —> Alopecia
- GI mucosa —> N+V, Diarrhoea
- Bone marrow —> BM suppression

  1. Preferentially treat malignant tumours but also treat **benign tumours / lesions as well
    - **
    Meningioma
    - **Acoustic (vestibular) schwannoma
    - Trigeminal neuralgia
    - Cavernous haemangioma
    - **
    AVM (by stereotactic radiosurgery)
    - Keloid scar
    - Aneurymsal bone cyst
    - Vertebral haemangioma
    - Heterotopic ossifications
    - **Graves’ ophthalmopathy
    - Orbital pseudotumour / idiopathic orbital inflammation
    - Pterygium
    - Pigmented villonodular synovitis
    - **
    Pleomorphic adenoma (recurrent)
    - ***Pituitary adenoma (recurrent)
    - Gynaecomastia after hormonal therapy for prostate cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

***Therapeutic ratio

A

Effect (on normal + tumour cells) (Y-axis) vs Radiation dose (X-axis):
- Sigmoidal curve (contain an exponential phase)
- Tumour cell curve ↑ much earlier than Normal cell curve (∵ more susceptible to radiation)
—> separate wider when ↑ dose (**↑ tumour cell killing)
—> ↑ up to a point of maximum **
therapeutic ratio (widest margin: max tumour cell killing with minimal normal cell damage)
—> just before plateau phase / turning point of tumour cell curve
—> further ↑ dose —> narrow the gap (∵ normal cell curve now exponential phase —> now also susceptible to radiation —> necrosis i.e. ***↑ SE)

  • Fully makes use of difference of cell **killing and **regeneration capacities of tumour cells + normal cells to achieve the ***maximum therapeutic ratio

Implications:
1. Cannot just rely on RT as sole modality for treatment
—> need ***other modalities to widen therapeutic ratio

  1. More advanced radiation techniques can wide therapeutic ratio
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Linear accelerator

A

3 components:
1. Electron gun (Cathode emit electron —> accelerated by electromagnetic field —> up to 1000x original speed —> hit tungsten —> emit X-ray)
2. Gantry
3. Couch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RT planning (電療設計 / 放射治療設計)

A

Purposes:
1. Pre-planning
- Clinical evaluation + Staging (TNM for solid tumours, Ann-Arbor for haematological malignancies)
- **Intent: **Radical / Curative vs ***Palliative
- Choice of treatment: Surgery, RT, Chemo, Targeted, Immunotherapy, Combination

  1. RT planning (after deciding on using RT)
    - Patient immobilisation (e.g. by thermoplastic cast) —> ↓ collateral damage
  • ***Image acquisition of tumour (e.g. CXR, CT, MRI, PET)
    —> Contouring of radiation field
    —> Shielding of important structures (e.g. neurostructures: brainstem, cerebellum, spinal cord) (otherwise paralysis / death)
  • Choice of ***technique + beam modification
  • ***Calculation of dose distribution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2-dimensional RT

A

Old technique: Narrow therapeutic ratio

Prone to radiate other unnecessary structures:
1. Temporal lobe —> Temporal necrosis (may require steroid / surgery to resect)
2. Brainstem
3. Optic nerve, chiasm, lenses
4. Parotid glands —> Xerostomia
5. Jaw / Mandible / TMJ joint —> Osteonecrosis of jaw, Trismus, Neck fibrosis
6. Molar
7. Tongue
8. Spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intensity Modulated RT (IMRT (強度調適放射治療))

A
  • Makes use of **multiple beams directed to tumour at **different angles (e.g. 9 fields)
  • **Intensity of radiation dose in each beam can be further modified
    —> create a **
    dose gradient to the tumour + surrounding normal structures (i.e. higher dose to tumour + lower dose to normal structures)
  • PET/CT + MRI co-registration (overlap 2 images) for tumour contouring
    —> MRI for drawing accurately exact tumour location
    —> Computer to calculate radiation dose based on CT scan
  • PET/CT for diagnosis of subtle synchronous tumour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

***2D RT vs IMRT

A

2D RT:
- Based on films
- **Less detailed localisation of tumour + normal structures
- **
Planning time shorter
- Easy set-up
- Shorter delivery time
- Mainly for **palliative treatment, occasional for **early-staged disease with simple set-up (e.g. T1N0 glottic cancer, T1N0 NPC, cervical / uterine cancer)
- SE esp. chronic SE more severe

IMRT:
- Based on CT images
- **Detailed localisation
- **
Planning time much longer (computer planning)
- Complicated set-up
- Longer delivery RT
- Mainly for ***radical treatment aiming to give an escalated radical dose
- SE esp. chronic SE less severe
- ?More radiation-induced secondary malignancies (risk: 1 in 10,000 ∵ RT delivered at multiple angle)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Image-guided RT (IGRT (影像導航放射治療))

A
  • Even immobilised by thermoplastic cast, patients / tumours can still move 1-2 mm in all directions
  • Also set up error of 1-2 mm as well
  • ***Real-time imaging before each treatment can provide important information on patient + tumour location
    —> Detect + Correct set-up error / discrepancies before Rx
  • Monitor body contour during course of RT

Indications:
- Tumours with **undetectable organ motions during treatment / sites with **dramatic change of body contour during RT
—> **Prostate cancer (position varies depending on bladder + rectum)
—> **
H+N cancer (esp. neck LN +ve tumour) which shrink rapidly during RT / ChemoRT

Limitations:
- Cannot manage large discrepancies
—> e.g. severe weight loss —> have to re-plan everything again (e.g. CT contouring, thermoplastic cast, dose calculation again)

Components:
1. Linear accelerator (Mega voltage)
2. Cone-beam CT (Kilo voltage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cyberknife (數碼導航刀)

A
  • Linear accelerator equipped with a ***robotic arm —> able to rotate at every angle
  • ***Long RT delivery time ∵ small gantry size (3-5 cm) —> small area of irradiation
  • Currently only available in private sector

Indication:
- ***Small tumours (<3 cm) close to normal critical structures (e.g. spinal cord compression, brain metastasis / tumours close to brainstem / optic nerve / chiasm / spinal cord)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Stereotactic radiosurgery (SRS (立體定向放射外科手術))

A

Types:
1. **X-knife
2. **
Gamma-knife
—> Multiple X-ray / Gamma rays (Very high dose) from ***different angles converging to the tumour

  • Delivered in (**one fraction only **18-20 Gy (Very high dose) (or few fractions only: Stereotactic (Fractionated) RT (SRT))
  • ***Very complicated set-up for immobilisation (if irradiate wrong position —> can be serious consequences)
    —> past: stereotactic head frame to fixed head
    —> current: frameless head frame
  • ***Long RT delivery time

Indications (small tumour + important structures nearby):
1. Brain metastases (max. 3, <3 cm each)
2. Meningioma
3. Acoustic neuroma (Vestibular schwannoma)
4. Cavernous haemangioma
5. Glomus jugulare
6. AVM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Charged-particle therapy (帶電粒子治療)

A

Overcome inherent limitations of X-ray (Photons)
- Inverse square law: ↑ tissue depth —> ↓ radiation intensity

Charged-particle:
- Characteristic peak of max dose deposition at a certain depth (Radiation intensity ↑ sharply then ↓ sharply) (***Bragg peak) for each type of charged particle
—> align to location of tumour
—> allow very high radiation dose while sparing unnecessary organs

Types of Charged-particle therapy:
1. Proton (most commonly used)
2. Carbon ion
3. Neon

The machine (Cyclotron) that produces proton takes a lot of space (~half of a football pitch!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proton therapy (質子治療)

A
  • ***Hydrogen ion carrying 1+ charge

Indications:
- Best for **small tumours close to critical structures where a **rapid dose fall-off is essential to avoid radiation-induced permanent damage
—> orbits / optic nerve / chiasm / pituitary
—> spinal cord
—> brainstem

Examples:
- Orbital tumours (e.g. Uveal melanoma (need to protect fovea / macula))
- Ependymomas of spinal cord
- Paediatric brain tumours (protect developing brain)
- Prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Brachytherapy (短距治療)

A

Brachy: within a short distance
- Delivery of RT by placing radioactive sources (e.g. I-125, Iridium-192 etc.) (β + **γ emissions) in **close proximity to tumours e.g. prostate cancer, cervical cancer, uterine cancer, rectum / anus, recurrent NPC etc.

Types:
1. Interstitial brachytherapy
- ***neck nodal recurrences in NPC / H+N cancer
- lip cancer
- breast cancer

  1. Intracavitary brachytherapy
    - **uterine cavity / vagina for cervical cancer —> spare skin / muscles
    - **
    nostrils for NPC
    - breast cancer
  2. Endoluminal brachytherapy (e.g. lung, rectal cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Intra-cavitary partial organ irradiation

A
  • Traditionally, when RT is needed for breast cancer, usually the whole breast is
    irradiated
  • Recently found that majority (>90%) of local recurrence is in the ***vicinity of original site of tumour for stage I cancer
  • Irradiation of partial breast (only irradiate on close proximity sites) may provide similar cure rate but better cosmetic outcome compared with whole-breast RT
  1. Single catheter balloon intracavitary brachytherapy
  2. Multi-catheter balloon intracavitary brachytherapy
    —> Load catheter into surgical cavity
    —> Inflate balloon to fit surgical cavity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

***External beam RT vs Brachytherapy

A

External beam RT:
- Delivered by an **external machines (e.g. linear accelerator, tomotherapy, cyberknife)
- Mainly **
X-rays, **Protons, **Electrons
- Must penetrate through the skin before reaching the tumour

Brachytherapy:
- Delivered by **radioisotopes (e.g. I-131, I-125, Iridium-192, Yttrium-90)
- Mainly **
β + ***γ emissions
- Dose to skin is less in general ∵ internal radiation

17
Q

Selective Internal RT (SIRT (選擇性體內放射治療))

A

A types of targeted radioactive **endovascular therapy that uses **microspheres to deliver ionising radiation to hepatic tumours (most commonly used for HCC / liver metastases from CRC)
- Size of microspheres ~30-35 micrometres (~ diameter of feeding hepatic arteries of tumours)

Example:
- **Yttrium-90 microspheres
—> emits 2.3 MeV **
β-radiation only (NO γ-radiation) with a t1/2 64 hours and a maximum penetration of 11 mm respectively, lodged preferentially in the vascular plexi of hepatic tumours, which draw their blood supply mainly from hepatic arteries
—> 1. Cut off blood supply from **embolisation effect
—> 2. **
Local irradiation with therapeutic doses to the tumours but tolerable dose to normal liver parenchyma + surrounding

Indication:
Safe and effective used alone / in combination with other local ablative therapy:
- TACE
- Percutaenous ethanol injection (PEI)
- RFA
- Systemic IV chemotherapy

SE of SIRT for liver tumours:
- **N+V (∵ microspheres lodged in gastroduodenal artery)
- **
Gastritis / Duodenitis / Ulcers (∵ microspheres lodged in gastroduodenal artery)
- **Radiation-induced liver injury
- **
Radiation pancreatitis (∵ microspheres lodged in pancreaticoduodenal artery)
- ***Radiation-fibrosis of lungs (∵ lung shunting)

18
Q

“Hyper” Selective IRT vs Non-selective IRT

A

“Hyper” SIRT:
- e.g. Yttrium-90 microspheres SIRT for liver tumours
- **Endovascular therapy
- Radioisotopes **
directly injected into feeding arteries of tumours

Non-selective IRT:
- e.g. I-131 for goitre, CA thyroid (taken up by follicular cells)
- e.g. Sr-89, Sa-153 for bone metastasis (carry 2+ charge —> similar to Ca —> preferentially taken up by osteoclast)
- Radioisotopes **NOT injected into feeding arteries of tumours but they are **preferentially taken up by specific organs

19
Q

Radiation therapy in combination with Targeted therapy

A

Epidermal growth factor receptor (EGFR)
- a member of the ErbB family of receptor tyrosine kinases, is abnormally activated in epithelial cancers, including H+N cancer (80-90%), associated with poor clinical outcome

Radiation **↑ expression of EGFR in cancer cells
—> blockade of EGFR signaling by Targeted therapy **
sensitises cells to the effects of radiation
—> ***Synergistic effect

Cetuximab
- IgG1 chimeric monoclonal Ab against the ligand-binding domain of EGFR, enhancing the cytotoxic effects of radiation in SCC
- initially used for metastatic CRC
- found effective when used with RT in H+N cancers

20
Q

Radioimmunotherapy

A

A monoclonal Ab ***conjugated to a radiolabelled substance
- combination of Targeted therapy + Brachytherapy

Example:
- Ibritumomab (Anti-CD20 monoclonal Ab (Rituximab) conjugated to Yttrium-90) for non-Hodgkin’s lymphoma (mainly follicular and mantle cell lymphoma)
- Tositumomab (Anti-CD20 monoclonal Ab (Rituximab) conjugated to I-131 (β+γ)) for non-Hodgkin’s lymphoma (mainly follicular and mantle cell lymphoma)

21
Q

Chemoradiation

A

Certain chemotherapeutic agents act as **radio-sensitiser
—> potentiating effect of RT (when used **
concurrently with RT (X induction / adjuvant))

Commonly used in H+N cancer, NSCLC, SCLC, esophagus, stomach, cervix, rectum, anus, GBM, medulloblastoma, rhabdomyosarcoma +/- pancreas / gallbladder / urinary bladder

Limitations:
1. More acute + long-term but manageable SE e.g. mucositis, pain etc.
2. Only ***a few chemotherapeutic agents can be safely used concurrently with RT
- Cisplatin/carboplatin/oxaliplatin
- 5-FU, capecitabine
- Paclitaxel
- Temozolomide
- Etoposide
- Mitomycin
- Vincristine

**NOT anthracyclines ∵ severe radio-sensitising SE (i.e. **Over-radiosensitising)

22
Q

Abscopal effect of RT (伴隨遠隔效應 aka 隔山打牛)

A

Mechanism:
- ↑ in **Ag presentation by myeloid cells within the tumour stroma —> enhance **T-cell killing of tumour cells
- esp. more prominent in melanoma, RCC, lymphoma (aka Immune-related cancers)

23
Q

Summary

A
  • RT is an important integral component of treatment for both malignant and some benign conditions
  • RT technologies have progressed very rapidly in the past few decades
  • New technologies have increased significantly the ***therapeutic ratios leading to better treatment outcomes and favourable toxicities
  • New technologies can also be safely combined with other cancer treatment modalities
24
Q

***Summary of RT modalities

A
  1. IMRT (Intensity Modulated RT)
  2. IGRT (Image-guided RT)
  3. Cyberknife
  4. Stereotactic radiosurgery (SRS)
  5. Charged-particle therapy
    - Proton (most commonly used)
    - Carbon ion
    - Neon
  6. Brachytherapy
    - Interstitial
    - Intracavitary
    - Endoluminal
  7. SIRT (Selective Internal RT)
    - Yttrium-90 microspheres
  8. Combination
    - Chemoradiation
    - RT + Targeted therapy
    - Radioimmunotherapy
25
Q

***SE of RT

A

Acute:
1. **Mucositis / Sore throat
2. **
Odynophagia / Dysphagia
3. **Xerostomia
4. Oral candidiasis
5. **
Hearing impairment / Tinnitus / Otitis media
6. ***Desquamation

Chronic (common):
1. Xerostomia
2. Hearing impairment / Tinnitus / Otitis media
3. Hyperpigmentation of skin
4. ***Fibrosis of neck muscles / Neck stiffness

Chronic (uncommon):
1. **Brain necrosis
2. **
Hypopituitarism
3. **Trismus
4. **
Osteonecrosis of jaw
5. Esophageal stricture
6. ***Carotid stenosis
7. Hypothyroidism
8. Radiation-induced secondary malignancy